Marcus Dunford-Castro
Stock Analyst at Jefferies
(1.08)
# 3,891
Out of 4,703 analysts
79
Total ratings
48.6%
Success rate
-2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marcus Dunford-Castro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CRDA Croda International Plc | Maintained: Buy | n/a | $3,296.00 | - | 2 | Sep 1, 2026 | |
| LON: 0Q4U Novozymes A/S | Maintained: Buy | kr 480.00 → kr 540.00 | kr 444.75 | +21.42% | 3 | Sep 1, 2026 | |
| EPA: RBT Robertet SA | Maintained: Buy | €950.00 → €930.00 | €797.00 | +16.69% | 2 | Sep 1, 2026 | |
| ETR: SY1 Symrise AG | Upgraded: Buy | €80.00 → €110.00 | €90.40 | +21.68% | 5 | Sep 1, 2026 | |
| SWX: GIVN Givaudan SA | Downgraded: Hold | CHF 3,700 → CHF 3,030 | CHF 3,250 | -6.77% | 6 | Sep 1, 2026 | |
| AMS: DSFIR DSM-Firmenich AG | Maintained: Buy | n/a | $93.06 | - | 2 | Sep 1, 2026 | |
| ETR: BNR Brenntag SE | Maintained: Hold | €56.00 | €61.16 | -8.44% | 6 | Aug 12, 2026 | |
| ETR: SDF K+S Aktiengesellschaft | Maintained: Sell | €10.50 | €16.83 | -37.61% | 8 | Aug 12, 2026 | |
| ETR: LXS LANXESS Aktiengesellschaft | Maintained: Sell | €14.00 | €15.52 | -9.79% | 10 | Aug 7, 2026 | |
| AMS: AKZA Akzo Nobel N.V. | Maintained: Hold | €55.00 | €60.74 | -9.45% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | CHF 6.00 → CHF 10.20 | CHF 10.59 | -3.68% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €185.44 → €204.00 | €170.44 | +19.69% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 470.00 → kr 480.00 | kr 455.84 | +5.30% | 7 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €49.00 → €44.00 | €53.36 | -17.54% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €18.00 → €20.00 | €26.06 | -23.25% | 2 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €93.00 | €92.30 | +0.76% | 10 | Jun 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €84.00 | €84.20 | -0.24% | 1 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €12.20 | €18.60 | -34.41% | 1 | Feb 5, 2026 |
Croda International Plc
Sep 1, 2026
Maintained: Buy
Price Target: n/a
Current: $3,296.00
Upside: -
Novozymes A/S
Sep 1, 2026
Maintained: Buy
Price Target: kr 480.00 → kr 540.00
Current: kr 444.75
Upside: +21.42%
Robertet SA
Sep 1, 2026
Maintained: Buy
Price Target: €950.00 → €930.00
Current: €797.00
Upside: +16.69%
Symrise AG
Sep 1, 2026
Upgraded: Buy
Price Target: €80.00 → €110.00
Current: €90.40
Upside: +21.68%
Givaudan SA
Sep 1, 2026
Downgraded: Hold
Price Target: CHF 3,700 → CHF 3,030
Current: CHF 3,250
Upside: -6.77%
DSM-Firmenich AG
Sep 1, 2026
Maintained: Buy
Price Target: n/a
Current: $93.06
Upside: -
Brenntag SE
Aug 12, 2026
Maintained: Hold
Price Target: €56.00
Current: €61.16
Upside: -8.44%
K+S Aktiengesellschaft
Aug 12, 2026
Maintained: Sell
Price Target: €10.50
Current: €16.83
Upside: -37.61%
LANXESS Aktiengesellschaft
Aug 7, 2026
Maintained: Sell
Price Target: €14.00
Current: €15.52
Upside: -9.79%
Akzo Nobel N.V.
Aug 6, 2026
Maintained: Hold
Price Target: €55.00
Current: €60.74
Upside: -9.45%
Aug 6, 2026
Upgraded: Hold
Price Target: CHF 6.00 → CHF 10.20
Current: CHF 10.59
Upside: -3.68%
Jul 28, 2026
Maintained: Buy
Price Target: €185.44 → €204.00
Current: €170.44
Upside: +19.69%
Jul 21, 2026
Maintained: Hold
Price Target: kr 470.00 → kr 480.00
Current: kr 455.84
Upside: +5.30%
Jun 30, 2026
Maintained: Hold
Price Target: €49.00 → €44.00
Current: €53.36
Upside: -17.54%
Jun 30, 2026
Maintained: Sell
Price Target: €18.00 → €20.00
Current: €26.06
Upside: -23.25%
Jun 21, 2026
Maintained: Hold
Price Target: €93.00
Current: €92.30
Upside: +0.76%
Apr 23, 2026
Maintained: Buy
Price Target: €84.00
Current: €84.20
Upside: -0.24%
Feb 5, 2026
Maintained: Sell
Price Target: €12.20
Current: €18.60
Upside: -34.41%